-
Congenital heart disease team grants to drive interdisciplinary research collaboration
https://braincanada.ca/about/news-updates/congenital-heart-disease-team-grants-to-drive-interdisciplinary-research-collaborationNew research funding will enable optimal wellness and health outcomes for people living with CHD, their families, and caregivers Heart & Stroke, together with Brain Canada, the Canadian Institutes of Health Research (CIHR) Institute of Circulatory and Respiratory Health and Institute of Genetics,...
-
Connecting cellular signalling data with behavioural and clinical outcomes for 5-HT receptor ligands
https://braincanada.ca/funded-grants/connecting-cellular-signalling-data-with-behavioural-and-clinical-outcomes-for-5-ht-receptor-ligandsThe Challenge: Current therapies for treating a number of mental health disorders – depression, anxiety, and PTSD, among them – adequately treat only a small fraction of afflicted patients. Project Overview The Challenge: Current therapies for treating a number of mental health disorders –...
-
CONP: The Canadian Open Neuroscience Platform
https://braincanada.ca/about/news-updates/conp-the-canadian-open-neuroscience-platformThe Canadian Open Neuroscience Platform (CONP) is a national platform for open sharing of neuroscience research data and brings together many of the country’s leading scientists in basic and clinical neuroscience to form an interactive network of collaborations in brain research, interdisciplinary...
-
Conquering brain disease requires both private and government funding
https://braincanada.ca/about/news-updates/conquering-brain-disease-requires-both-private-and-government-fundingNAOMI AZRIELI CONTRIBUTED TO THE GLOBE AND MAIL DECEMBER 27, 2017 Naomi Azrieli is chair and CEO of the Azrieli Foundation and chair of Brain Canada Fifty years ago, when someone was diagnosed with cancer, it was often an automatic death sentence. Likewise at that time, a heart attack was met...
-
Control of mRNA translation in Microglia response to Alzheimer’s disease pathology
https://braincanada.ca/funded-grants/control-of-mrna-translation-in-microglia-response-to-alzheimer-s-disease-pathologyMicroglia are the brain’s immune cells, and their role is to protect the brain. Project Overview Microglia are the brain’s immune cells, and their role is to protect the brain. Yet in Alzheimer’s disease, these cells are often found diseased as well. In a brain with Alzheimer’s disease, the...
-
Cooking Together: promotions and resource development
https://braincanada.ca/funded-grants/cooking-together-promotions-and-resource-developmentCooking Together is an innovative project that provides the opportunity for developing new relationships between generations while cooking and eating together. Project Overview Cooking Together is an innovative project that provides the opportunity for developing new relationships between...
-
Coordinating Global Brain Projects
https://braincanada.ca/about/news-updates/coordinating-global-brain-projectsInez Jabalpurwala, Brain Canada’s President and CEO, speak at the at Rockefeller University on September 19, 2016.
-
Correction of Neuronal Function in Autism
https://braincanada.ca/funded-grants/correction-of-neuronal-function-in-autismThe prevalence of autism spectrum disorders (ASDs) is rising dramatically on a yearly basis and new interventional strategies are required to treat ASDs and related disorders like Fragile X syndrome. Project Overview The prevalence of autism spectrum disorders (ASDs) is rising dramatically on a...
-
Correlating quaternary structure of pathological protein aggregates with phenotypic presentation of ALS
https://braincanada.ca/funded-grants/correlating-quaternary-structure-of-pathological-protein-aggregates-with-phenotypic-presentation-of-alsAmyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset. Project Overview Amyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset. The disease can start in one arm, leg,...
-
Cortical GABAergic interneurons migration impairment in genetic epileptic encephalopathies
https://braincanada.ca/funded-grants/cortical-gabaergic-interneurons-migration-impairment-in-genetic-epileptic-encephalopathiesDr. Eid will test the hypothesis that the Trio gene is a central regulator of the development and maturation of cortical interneurons (INs) and that its loss underlies some genetic forms of epileptic encephalopathies (EE) by disrupting cortical network development and function. Project Overview Dr....